Literature DB >> 176466

Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides.

B D Korant, B E Butterworth.   

Abstract

Zinic ions rapidly inhibit virus production in HeLa cells infected with human rhinovirus type 1A and lead to the accumulation of human rhinovirus type 1A precursor polypeptides. The degree to which cleavage of these precursors is inhibited is directly dependent on the quantity of cell-associated zinc. Proteolysis resumes after the removal of zinc-containing medium, and the accumulated viral precursors are cleaved predominantly to stable virus polypeptides. The precursors stabilized at the lowest zinc levels are those that contain capsid protein sequences. Furthermore, added zinc is bound to human rhinovirus type 1A capsids and prevents them from forming crystals. Zinc-resistant mutants display antigenic alterations in coat proteins. These results suggest that zinc complexes with rhinovirus coat proteins and alters them so that they cannot function as substrates for proteases or as reactants in the assembly of the virus particles.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176466      PMCID: PMC515548     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Inhibition of initiation of protein synthesis in mammalian tissue culture cells by L-1-tosylamido-2-phenylethyl chloromethyl ketone.

Authors:  S S Pong; D L Nuss; G Koch
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

2.  Identification of a viral protein involved in post-translational maturation of the encephalomyocarditis virus capsid precursor.

Authors:  C Lawrence; R E Thach
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

3.  Irreversible inhibition of herpes simplex virus replication in BSC-1 cells by zinc ions.

Authors:  Y J Gordon; Y Asher; Y Becker
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

4.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

5.  Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

Authors:  B E Butterworth; B D Korant
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

6.  Zinc ions inhibit replication of rhinoviruses.

Authors:  B D Korant; J C Kauer; B E Butterworth
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

7.  A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus.

Authors:  B E Butterworth
Journal:  Virology       Date:  1973-12       Impact factor: 3.616

8.  Further evidence on the formation of poliovirus proteins.

Authors:  M F Jacobson; J Asso; D Baltimore
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

9.  Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences.

Authors:  F H Yin; K Lonberg-Holm; S P Chan
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

10.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

View more
  26 in total

1.  Polypeptide synthesis in simian virus 5-infected cells.

Authors:  R W Peluso; R A Lamb; P W Choppin
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

2.  Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli.

Authors:  M G Cordingley; R B Register; P L Callahan; V M Garsky; R J Colonno
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  In vitro activity of zinc salts against human rhinoviruses.

Authors:  F C Geist; J A Bateman; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

4.  Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds.

Authors:  B M Farr; E M Conner; R F Betts; J Oleske; A Minnefor; J M Gwaltney
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 5.  Transmission and control of rhinovirus colds.

Authors:  L C Jennings; E C Dick
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

Authors:  B M Krenn; B Holzer; E Gaudernak; A Triendl; F J van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  Chemotherapy of rhinovirus colds.

Authors:  S J Sperber; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

8.  The correlation between prognosis of HCMV infection and zinc in mature women.

Authors:  Dan Li; Liangzhen Wen; Hui Yuan; Nan Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

9.  Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study.

Authors:  G A Eby; D R Davis; W W Halcomb
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  Failure of zinc gluconate in treatment of acute upper respiratory tract infections.

Authors:  D S Smith; E C Helzner; C E Nuttall; M Collins; B A Rofman; D Ginsberg; C B Goswick; A Magner
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.